Clinical Trial Detail

NCT ID NCT02861040
Title Volasertib and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Northwestern University
Indications

acute lymphoblastic leukemia

Therapies

Vincristine Sulfate + Volasertib

Age Groups: adult senior

No variant requirements are available.